The company is looking for noninvasive or minimally invasive devices that can easily measure various biomarkers (blood glucose level, hydration, sodium levels). Such devices need to be commercialized for general consumers by 2020.
In recent years, the commercialization of consumer devices for noninvasive or minimally invasive blood glucose level monitoring has become realistic. Soon, general consumers will be able to measure other major biomarkers to more easily help maintain a healthy life. Consumers are expected to ask for devices that easily measure biomarkers such as hydration and sodium levels in both the blood and in interstitial fluid.
We are considering offering new services by combining such measurement devices with food and drink.
We are looking forward to receiving proposals for noninvasive/minimally invasive biomarker measurement equipment that can be commercialized for consumers by 2020.
Biomarker measurement devices (blood glucose level, hydration, sodium levels)
- It is not necessary for your device to be approved as a medical device, but it is necessary to be approved as measurement equipment in countries such as Japan, the United States, and Europe in the future.
- Noninvasive and minimally invasive measurements are essential.
- Large devices are also of interest, but they need to have simple measurement processes. Consumers need to manage the devices easily.
We do not place any constraints on the type of deal.
Basically, we will consider collaborative research with the company that has developed or is currently developing the measuring devices. Then, through such devices, we would like to demonstrate the effectiveness of our food/beverage products to consumers.
Possible solution areas:
Medical and healthcare industry
Within 12 months
Field Of Use and Intended Application:
Your proposed solution must be noninvasive or minimally invasive and have practical tolerance/accuracy.